Laboratorios Farmaceuticos Rovi, S.A. Stock Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.65 EUR | -1.01% |
|
-1.35% | -7.35% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.99B 3.45B 2.8B 2.57B 4.84B 328B 4.92B 32.96B 12.91B 164B 12.94B 12.66B 540B | P/E 2026 * |
20.9x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.98B 3.43B 2.78B 2.55B 4.81B 327B 4.9B 32.79B 12.84B 163B 12.87B 12.59B 537B | EV / Sales 2026 * |
3.86x | EV / Sales 2027 * | 3.27x |
| Free-Float |
31.63% | Yield 2026 * |
1.64% | Yield 2027 * | 2% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -1.01% | ||
| 1 week | -1.35% | ||
| 1 month | +3.26% | ||
| 3 months | -26.27% | ||
| 6 months | -19.66% | ||
| Current year | -7.35% |
| 1 week | 58.55 |  | 59.95 |
| 1 month | 53.15 | | 59.95 |
| Current year | 53.15 | | 86.6 |
| 1 year | 51.85 | | 86.6 |
| 3 years | 45.82 | | 90.75 |
| 5 years | 35.64 | | 90.75 |
| 10 years | 35.64 | | 90.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.01% | -1.35% | - | - | 3.44B | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1,024B | |
| -0.76% | -4.34% | +52.04% | +49.09% | 618B | |
| -2.33% | -4.60% | +25.55% | +64.44% | 443B | |
| +0.68% | -1.14% | +38.47% | +33.36% | 349B | |
| -1.66% | -3.13% | +32.18% | +39.79% | 297B | |
| -8.96% | -10.77% | +3.57% | +5.50% | 264B | |
| -1.37% | -7.41% | -2.10% | -43.67% | 209B | |
| -1.63% | +0.69% | +27.62% | +64.23% | 208B | |
| +0.72% | +0.48% | +15.88% | +73.64% | 162B | |
| Average | -1.48% | -3.14% | +26.70% | +48.45% | 397.08B | |
| Weighted average by Cap. | -0.98% | -3.91% | +34.56% | +70.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 772M 888M 720M 661M 1.25B 84.63B 1.27B 8.5B 3.33B 42.2B 3.34B 3.26B 139B | 891M 1.02B 832M 763M 1.44B 97.7B 1.46B 9.81B 3.84B 48.72B 3.85B 3.76B 161B |
| Net income | 129M 148M 120M 110M 208M 14.1B 211M 1.42B 554M 7.03B 556M 543M 23.19B | 174M 200M 162M 149M 281M 19.07B 286M 1.91B 750M 9.51B 752M 735M 31.37B |
| Net Debt | -16.21M -18.66M -15.14M -13.9M -26.2M -1.78B -26.66M -178M -69.9M -887M -70.07M -68.52M -2.92B | -81.51M -93.78M -76.1M -69.86M -132M -8.94B -134M -897M -351M -4.46B -352M -344M -14.7B |
| Date | Price | Change |
|---|---|---|
| 03/08/26 | €58.55 | -0.17% |
| 31/07/26 | €58.65 | -1.01% |
| 30/07/26 | €59.25 | -1.17% |
| 29/07/26 | €59.95 | +1.01% |
| 28/07/26 | €59.35 | -0.17% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
